Patent court to review Alexions Soliris patents on Amgen challenge
By Manas Mishra and Manojna Maddipatla
The U.S. patent office will review patents on Alexion Pharmaceuticals Incs blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.
Click one of our representatives below to chat on WhatsApp ,no call facility whatsaap this numbers only Chat .
Sales manager Supporter Manger
How can i help you?Sales manager Supporter MangerI am online